Tenax Therapeutics (TENX) Change in Receivables (2022 - 2025)
Tenax Therapeutics recorded quarterly Change in Receivables of -$1.2 million in Q1 2025, down 439.37% quarter-over-quarter from $360670.0 in Q4 2024, and down 6900.0% year-over-year from $18000.0 in Q1 2024.
Tenax Therapeutics' Change in Receivables history runs 4 years deep, the most recent figure standing at -$1.2 million for Q1 2025.
- In Q1 2025, Change in Receivables fell 6900.0% year-over-year to -$1.2 million; the TTM figure through Mar 2025 stood at -$1.3 million (down 332.64% YoY), while the FY2024 annual figure was -$58000.0, down 118.95% from the prior year.
- Change in Receivables came in at -$1.2 million for Q1 2025 at Tenax Therapeutics, down from $360670.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $963079.0 in Q4 2022 to a low of -$1.4 million in Q3 2022.
- A 4-year average of -$126439.5 and a median of -$36834.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 1079.18% in 2024 and tumbled 6900.0% in 2025, its largest moves.
- Tenax Therapeutics' Change in Receivables stood at $963079.0 in 2022, then tumbled by 103.82% to -$36834.0 in 2023, then surged by 1079.18% to $360670.0 in 2024, then plunged by 439.37% to -$1.2 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$1.2 million, $360670.0, and $240931.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1.22 Mn |
| Mar 31, 2025 | -1.22 Mn |
| Dec 31, 2024 | 360,670.00 |
| Dec 31, 2024 | 360,670.00 |
| Sep 30, 2024 | 240,931.00 |
| Sep 30, 2024 | 240,931.00 |
| Jun 30, 2024 | -677,601.00 |
| Jun 30, 2024 | -677,601.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | -36,834.00 |
| Dec 31, 2023 | -36,834.00 |
| Sep 30, 2023 | 782,483.00 |
| Sep 30, 2023 | 782,483.00 |
| Jun 30, 2023 | -204,847.00 |
| Jun 30, 2023 | -204,847.00 |
| Mar 31, 2023 | -234,802.00 |
| Mar 31, 2023 | -234,802.00 |
| Dec 31, 2022 | 963,079.00 |
| Dec 31, 2022 | 963,079.00 |
| Sep 30, 2022 | -1.38 Mn |
| Sep 30, 2022 | -1.38 Mn |